Novel effect of C75 on carnitine palmitoyltransferase I activity and palmitate oxidation

Biochemistry

Volumn 45, Issue 14, 2006, Pages 4339-4350

  Bentebibel, Assia ^a   Sebastián, David ^a   Herrero, Laura ^a   López Viñas, Eduardo ^b   Serra, Dolors ^a   Asins, Guillermina ^a   Gómez Puertas, Paulino ^b   Hegardt, Fausto G ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITION; ENZYME KINETICS; FATTY ACIDS; MUSCLE; OXIDATION; TISSUE;

CARNITINE PALMITOYLTRANSFERASE I (CPT I); FATTY ACID SYNTHASE (FAS); IN SILICO MOLECULAR DOCKING;

DRUG THERAPY;

C 75; C 75 COENZYME A DERIVATIVE; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE INHIBITOR; ETOMOXIRYL COENZYME A; FATTY ACID SYNTHASE INHIBITOR; MALONYL COENZYME A; PALMITIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; FATTY ACID OXIDATION; IC 50; LIVER MITOCHONDRION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; MUSCLE MITOCHONDRION; NONHUMAN; OBESITY; PRIORITY JOURNAL;

4-BUTYROLACTONE; ACYL COENZYME A; ANIMALS; CARNITINE O-PALMITOYLTRANSFERASE; CELLS, CULTURED; COENZYME A LIGASES; EPOXY COMPOUNDS; HUMANS; KINETICS; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA, LIVER; MITOCHONDRIA, MUSCLE; OXIDATION-REDUCTION; PALMITIC ACID; RATS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

ANIMALIA;

EID: 33645655060     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi052186q     Document Type: Article

References (47)

1. Price, A. C., Choi, K.-H., Heath, R. J., Li, Z., White, S. W., and Rock, C. O. (2001) Inhibition of β-ketoacyl-acyl carrier protein syntheses by thiolactomycin and cerulenin. Structure and mechanism, J. Biol. Chem. 276, 6551-6559.
2. Rendina, A. R., and Cheng, D. (2005) Characterization of the inactivation of rat faty acid synthase by C75: Inhibition of partial reactions and protection by substrates, Biochem. J. 388, 895-903.
3. Li, J.-N., Gorospe, M., Chrest, F. J., Kumaravel, T. S., Evans, M. K., Han, W. F., and Pizer, E. S. (2001) Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53, Cancer Res. 61, 1493-1499.
4. Loftus, T. M., Jaworsky, D. E., Frehywot, G. L., Townsend, C. A., Ronnett, G. V., Lane, M. D., and Kuhajda, F. P. (2000) Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors, Science 288, 2379-2381.
5. Hu, Z., Cha, S. H., Chohnan, S., and Lane, M. D. (2003) Hypothalamic malonyl-CoA as a mediator of feeding behaviour, Proc. Natl. Acad. Sci. U.S.A. 100, 12624-12629.
6. Kim, E.-K., Miller, I., Landree, L. E., Borisy-Rudin, F. F., Brown, P., Tihan, T., Townsend, C. A., Witters, L. A., Moran, T. H., Kuhajda, F. P., and Ronnett, G. V. (2002) Expression of FAS within hypothalamic neurons: A model for decreased food intake after C75 treatment, Am. J. Physiol. 283, E867-E879.
7. Thupari, J. N., Landree, L. E., Ronnett, G. V., and Kuhajda, F. P. (2002) C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity. Proc. Natl. Acad. Sci. U.S.A. 99, 9498-9502.
8. McGarry, J. D., and Brown, N. F. (1997) The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis, Eur. J. Biochem. 244, 1-14.
9. Price, N., van der Leij, F., Jackson, V., Corstorphine, C., Thomson, R., Sorensen, A., and Zammit, V. A. (2002) A novel brain-expressed protein related to carnitine palmitoyltransferase I, Genomics 80, 433-442.
10. Grantham, B. D., and Zammit, V. A. (1986) Restoration of the properties of carnitine palmitoyltransferase I in liver mitochondria during re-feeding of starved rats, Biochem. J. 239, 485-488.
11. Grantham, B. D., and Zammit, V. A. (1988) Role of carnitine palmitoyltransferase I in the regulation of hepatic ketogenesis during the onset and reversal of chronic diabetes, Biochem. J. 249, 409-414.
12. Selby, P. L., and Sherratt, H. S. A. (1989) Substitutted 2-oxiranecarboxylic acids: A new group of candidate hypoglycaemic drugs, Trends Pharmacol. Sci. 10, 495-500.
13. Taylor, D. C., Weber, N., Hogge, L. R., and Underhill, E. W. (1990) A simple enzymatic method for the preparation of radiolabeled erucoyl-CoA and other long-chain fatty acyl-CoAs and their characterization by mass spectrometry, Anal. Biochem. 184, 311-316.
14. Fritz, I. B., and Schultz, S. K. (1965) Carnitine acetyltransferase. Inhibition by carnitine analogues and by sulfhydryl reagents, J. Biol. Chem. 240, 2188-2192.
15. Morillas, M., Gomez-Puertas, P., Roca, R., Serra, D., Asins, G., Valencia, A., and Hegardt, F. G. (2001) Structural model of the catalytic core of carnitine palmitoyltransferase I and carnitine octanoyltransferase (COT): Mutation of CPT I histidine 473 and alanine 381 and COT alanine 238 impairs the catalytic activity. J. Biol. Chem. 276, 45001-45008.
16. Yamazaki, N., Shinohara, Y., Shima, A., and Terada, H. (1995) High expression of a novel carnitine palmitoyltransferase I like protein in rat brown adipose tissue and heart: Isolation and characterization of its cDNA clone, FEBS Lett. 363, 41-45.
17. Jackson, V. N., Cameron, J. M., Fraser, P., Zammit, V. A., and Price, N. T. (2000) Use of six chimeric proteins to investigate the role of intramolecular interactions in determining the kinetics of carnitine palmitoyltransferase 1 isoforms, J. Biol. Chem. 275, 19560-19566.
18. Asfari, M., Janjic, D., Meda, P., Li, G., Halban, P. A., and Wollheim, C. B. (1992) Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines, Endocrinology 130, 167-178.
19. Rubi, B., Antinozzi, P. A., Herrero, L., Ishihara, H., Asins, G., Serra, D., Wollheim, C. B., Maechler, P., and Hegardt, F. G. (2002) Adenovirus-mediated overexpression of liver carnitine palmitoyltransferase 1 in INSIE cells: Effects on cell metabolism and insulin secretion, Biochem. J. 364, 219-226.
20. Saggerson, E. D., and Carpenter, C. A (1981) Carnitine palmitoyltransferase and carnitine octanoyltransferase activities in liver, kidney cortex, adipocyte, lactating mammary gland, skeletal muscle and heart, FEBS Lett. 129, 229-232.
21. Saggerson, E. D. (1982) Carnitine palmitoyltransferase activities in rat liver and heart measured with palmitoyl-CoA and octanoyl-CoA, Biochem. J. 202, 397-405.
22. Li, G., Kowluru, A., and Metz, S. A. (1996) Characterization of prenylcysteine methyltransferase in insulin-secreting cells. Biochem. J. 316, 345-351.
23. Kitz, R., and Wilson, I. B (1962) Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase, J. Biol. Chem. 237, 3245-3249.
24. Maurer, T., and Fung, H. L. (2000) Comparison of methods for analyzing kinetic data from mechanism-based enzyme inactivation: Application to nitric oxide synthase, AAPS Pharm. Sci. 2 (1), E8.
25. Tutwiler, G. F., and Ryzlak, M. T. (1980) Inhibition of mitochondrial carnitine palmitoyl transferase by 2-tetradecylglycidic acid (McN-3802), Life Sci. 26, 393-397.
26. 2-capture assay for evaluation of substrate oxidation rates of cells in culture, BioTechniques 24, 803-808.
27. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, J. Immunol. Methods 65, 55-63.
28. Jogl, G., Hsiao, Y. S., and Tong, L. (2005) Crystal structure of mouse carnitine octanoyltransferase and molecular determinants of substrate selectivity, J. Biol. Chem. 280, 738-744.
29. Stewart, J. J. (1990) MOPAC: A semiempirical molecular orbital program, J. Comput.-Aided Mol. Des. 4, 1-45.
30. Goodsell, D. S., Morris, G. M., and Olson, A, J. (1996) Automated docking of flexible ligands: Applications of AutoDock, J. Mol. Recognit. 9, 1-5.
31. Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, E., Belew, R. K., and Olson, A, J, (1998) Automated Docking Using a Lamarckian Genetic Algorithm and Empirical Binding Free Energy Function, J. Comput. Chem. 19, 1639-1662.
32. Morillas, M., López-Viñas, E., Valencia, A., Serra, D., Gómez-Puertas, P., Hegardt, F. G., and Asins, G. (2004) Structural model of carnitine palmitoyltransferase I based on the carnitine acetyltransferase crystal, Biochem. J. 379, 777-784.
33. Knights, K. M. (1998) Role of hepatic fatty acid:coenzyme A ligases in the metabolism of xenobiotic carboxylic acids, Clin. Exp. Pharmacol. Physiol. 10, 776-782.
34. Mashek, D. D. G., Bornfeldt, K. E., Coleman, R. A., Berger, J., Bernlohr, D. A., Black, P., DiRusso, C. C., Farber, S. A., Guo, W., Hashimoto, N., Khodiyar, V., Kuypers, F. A., Maltais, L. J., Nebert, D. W., Renieri, A., Schaffer, J. E., Stahl, A., Watkins, P. A., Vasiliou, V., and Yamamoto, T. T. (2004) Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family, J. Lipid Res. 45, 1958-1961.
35. Perdomo, G., Commerford, S. R., Richard, A. M., Adams, S. H., Corkey, B. E., O'Doherty, R. M., and Brown, N. F. (2004) Increased β-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation, J. Biol. Chem. 279, 27177-27186.
36. Yang, N., Kays, J. S., Skillman, T. R., Burris, L., Seng, T. W., and Hammond, C. (2005) C75 [4-methylene-2-octyl-5-oxo-tetrahydro-furan-3-carboxylic acid] activates carnitine palmitoyltransferase-1 in isolated mitochondria and intact cells without displacement of bound malonyl-CoA, J. Pharmacol. Exp. Ther. 312, 127-133.
37. Nicot, C., Napal, L., Relat, J., Gonzalez, S., Llebaria, A., Woldegiorgis, G., Marrero, P. F., and Haro, D. (2004) C75 activates malonyl-CoA sensitive and insensitive components of the CPT system, Biochem. Biophys. Res. Commun. 325, 660-666.
38. Weis, B. C., Cowan, A, T., Brown, N., Foster, D. W., and McGarry, J. D. (1994) Use of a selective inhibitor of liver carnitine palmitoyltransferase 1 (CPT I) allows quantification of its contribution to total CPT I activity in rat heart. Evidence that the dominant cardiac CPT I isoform is identical to the skeletal muscle enzyme, J. Biol. Chem. 269, 26443-26448.
39. Pizer, E. S., Thupari, J., Han, W. F., Pinn, M. L., Chrest, F. J., Frehywot, G. L., Townsend, C. A., and Kuhajda, F. P. (2000) Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts, Cancer Res. 60, 213-218.
40. Guzmán, M., Velasco, G., and Geelen, M. J. (2000) Do cytoskeletal components control fatty acid translocation into liver mitochondria? Trends Endocrinol. Metab. 11, 49-53.
41. Zammit, V. A., Corstorphine, C. G., Kolodziej, M. P., and Fraser, F. (1998) Lipid molecular order in liver mitochondrial outer membranes, and sensitivity of carnitine palmitoyltransferase I to malonyl-CoA, Lipids 33, 371-376.
42. Zammit, V. A. (1999) Carnitine acyltransferases: Functional significance of subcellular distribution and membrane topology, Prog. Lipid Res. 38, 199-224.
43. Yajima, H., Komatsu, M., Yamada, S., Straub, S. G., Kaneko, T., Sato, Y., Yamauchi, K., Hashizume, K., Sharp, G. W., and Aizawa, T. (2000) Cerulenin, an inhibitor of protein acylation, selectively attenuates nutrient stimulation of insulin release: A study in rat pancreatic islets, Diabetes 49, 712-717.
44. Jin, Y.-J., Li, S.-Z., Zhao, Z.-S., An, J. J., Kim, R. Y., Kim, Y. M., Baik, J.-H., and Lim, S.-K. (2004) Carnitine palmitoyltransferase-1 (CPT-I) activity stimulation by cerulenin via sympathetic nervous system activation overrides cerulenin's peripheral effect, Endocrinology 145, 3197-3204.
45. Clegg, D. J., Wortman, M. D., Benoit, S. C., McOsker, C. C., and Seeley, R. J. (2002) Comparison of central and peripheral administration of C75 on food intake, body weight, and conditioned taste aversion, Diabetes 51, 196-201.
46. Cha, S. H., Hu, Z., Chohnan, S., and Lane, M. D. (2005) Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle, Proc. Natl. Acad. Sci. U.S.A. 102, 14557-14562.
47. Rohrbach, K. W., Han, S., Can, J., O'Tanyi, E. J., Zhang, H., Chi, C. L., Taub, R., Largent, B. L., and Cheng, D. (2005) Disconnection between the early onset anorectic effects by C75 and hypothalamic fatty acid synthase inhibition in rodents, Eur. J. Pharmacol. 21, 31-41.